{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T14:40:40Z","timestamp":1787582440078,"version":"build-2736575974"},"reference-count":103,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T00:00:00Z","timestamp":1771372800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T00:00:00Z","timestamp":1771372800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Metab Brain Dis"],"DOI":"10.1007\/s11011-025-01780-x","type":"journal-article","created":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T10:53:07Z","timestamp":1771411987000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Neuro-renin\u2013angiotensin\u2013aldosterone system axis in alzheimer\u2019s disease: from molecular dysregulation to therapeutic redirection"],"prefix":"10.1007","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-1876-222X","authenticated-orcid":false,"given":"Gursimran","family":"Singh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7033-7790","authenticated-orcid":false,"given":"Kousik","family":"Maparu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2450-2975","authenticated-orcid":false,"given":"Khadga Raj","family":"Aran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,18]]},"reference":[{"issue":"9","key":"1780_CR1","doi-asserted-by":"publisher","first-page":"2290","DOI":"10.3390\/pharmRaaceutics15092290","volume":"15","author":"D-C Ababei","year":"2023","unstructured":"Ababei D-C, Bild V, Macadan I, Vasincu A, Rusu R-N, Blaj M, Stanciu GD, Lefter R-M, Bild W (2023) Therapeutic implications of renin-angiotensin system modulators in Alzheimer\u2019s Dementia. Pharmaceutics 15(9):2290. https:\/\/doi.org\/10.3390\/pharmRaaceutics15092290","journal-title":"Pharmaceutics"},{"issue":"3","key":"1780_CR2","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1016\/j.sjbs.2020.01.026","volume":"27","author":"OA Abiodun","year":"2020","unstructured":"Abiodun OA, Ola MS (2020) Role of brain renin angiotensin system in neurodegeneration: an update. Saudi J Biol Sci 27(3):905\u2013912. https:\/\/doi.org\/10.1016\/j.sjbs.2020.01.026","journal-title":"Saudi J Biol Sci"},{"key":"1780_CR3","doi-asserted-by":"publisher","first-page":"3458","DOI":"10.1007\/s12035-020-01964-9","volume":"57","author":"HA Ahmed","year":"2020","unstructured":"Ahmed HA, Ishrat T (2020) The brain AT2R\u2014a potential target for therapy in Alzheimer\u2019s disease and vascular cognitive impairment: a comprehensive review of clinical and experimental therapeutics. Mol Neurobiol 57:3458\u20133484. https:\/\/doi.org\/10.1007\/s12035-020-01964-9","journal-title":"Mol Neurobiol"},{"issue":"4","key":"1780_CR4","doi-asserted-by":"publisher","first-page":"C779","DOI":"10.1152\/ajpcell.00398.2003","volume":"286","author":"IA Arenas","year":"2004","unstructured":"Arenas IA, Xu Y, Lopez-Jaramillo P, Davidge ST (2004) Angiotensin II-induced MMP-2 release from endothelial cells is mediated by TNF-\u03b1. Am J Physiol Cell Physiol 286(4):C779\u2013C784. https:\/\/doi.org\/10.1152\/ajpcell.00398.2003","journal-title":"Am J Physiol Cell Physiol"},{"issue":"10","key":"1780_CR5","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1517\/13543784.2013.812631","volume":"22","author":"EL Ashby","year":"2013","unstructured":"Ashby EL, Kehoe PG (2013) Current status of renin\u2013aldosterone angiotensin system-targeting anti-hypertensive drugs as therapeutic options for Alzheimer\u2019s disease. Expert Opin Investig Drugs 22(10):1229\u20131242. https:\/\/doi.org\/10.1517\/13543784.2013.812631","journal-title":"Expert Opin Investig Drugs"},{"key":"1780_CR6","doi-asserted-by":"publisher","unstructured":"Bernocchi F, Bonomi CG, Assogna M, Moreschini A, Mercuri NB, Koch G & Motta C (2024) Astrocytic-derived vascular remodeling factors are independently associated with blood brain barrier permeability in Alzheimer\u2019s disease. Neurobiology of Aging, 141, 66\u201373. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2024.05.002","DOI":"10.1016\/j.neurobiolaging.2024.05.002"},{"key":"1780_CR7","doi-asserted-by":"publisher","unstructured":"Bild W, Vasincu A, Rusu RN, Ababei DC, Stana AB, Stanciu GD & Bild, V (2022) Impact of the renin-angiotensin system on the pathogeny and pharmacotherapeutics of neurodegenerative diseases. Biomolecules, 12(10), 1429. https:\/\/doi.org\/10.3390\/biom12101429","DOI":"10.3390\/biom12101429"},{"issue":"3","key":"1780_CR8","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1161\/HYPERTENSIONAHA.113.01743","volume":"63","author":"VC Biancardi","year":"2014","unstructured":"Biancardi VC, Son SJ, Ahmadi S, Filosa JA, Stern JE (2014) Circulating angiotensin II gains access to the hypothalamus and brain stem during hypertension via breakdown of the blood\u2013brain barrier. Hypertension 63(3):572\u2013579. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.113.01743","journal-title":"Hypertension"},{"issue":"24","key":"1780_CR9","doi-asserted-by":"publisher","first-page":"5789","DOI":"10.3390\/molecules25245789","volume":"25","author":"Z Breijyeh","year":"2020","unstructured":"Breijyeh Z, Karaman R (2020) Comprehensive review on Alzheimer\u2019s disease: causes and treatment. Molecules 25(24):5789. https:\/\/doi.org\/10.3390\/molecules25245789","journal-title":"Molecules"},{"key":"1780_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2025.107771","author":"F Buonfiglio","year":"2025","unstructured":"Buonfiglio F, B\u00f6hm EW, Tang Q, Daiber A, Gericke A (2025) Revisiting the renin-angiotensin-aldosterone system in the eye: mechanistic insights and pharmacological targets. Pharmacol Res. https:\/\/doi.org\/10.1016\/j.phrs.2025.107771","journal-title":"Pharmacol Res"},{"key":"1780_CR11","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.neuroscience.2017.01.027","volume":"346","author":"JL Chen","year":"2017","unstructured":"Chen JL, Zhang DL, Sun Y, Zhao YX, Zhao KX, Pu D, Xiao Q (2017) Angiotensin-(1\u20137) administration attenuates Alzheimer\u2019s disease-like neuropathology in rats with streptozotocin-induced diabetes via MasReceptor activation. Neuroscience 346:267\u2013277. https:\/\/doi.org\/10.1016\/j.neuroscience.2017.01.027","journal-title":"Neuroscience"},{"issue":"1","key":"1780_CR12","doi-asserted-by":"publisher","DOI":"10.1186\/s12987-024-00557-1","volume":"21","author":"T Chen","year":"2024","unstructured":"Chen T, Dai Y, Hu C, Lin Z, Wang S, Yang J, Zeng L, Li S, Li W (2024) Cellular and molecular mechanisms of the blood\u2013brain barrier dysfunction in neurodegenerative diseases. Fluids Barriers CNS 21(1):60. https:\/\/doi.org\/10.1186\/s12987-024-00557-1","journal-title":"Fluids Barriers CNS"},{"issue":"5","key":"1780_CR13","doi-asserted-by":"publisher","first-page":"afaf121","DOI":"10.1093\/ageing\/afaf121","volume":"54","author":"ECL Cheung","year":"2025","unstructured":"Cheung ECL, Adesuyan M, Szilcz M, KalischEllett LM, Shah S, Jani YH, H\u00e4gg S, Pratt N, Lau KK, Luo H (2025) Antihypertensive drug classes and risk of incident dementia: a multinational population-based cohort study. Age Ageing 54(5):afaf121. https:\/\/doi.org\/10.1093\/ageing\/afaf121","journal-title":"Age Ageing"},{"key":"1780_CR14","doi-asserted-by":"publisher","unstructured":"Chen F, Zhang Y, Li X, Li W, Liu X & Xue X (2021) The impact of ACE2 polymorphisms on COVID-19 disease: susceptibility, severity, and therapy.\u00a0Front Cell Infect Microbiol, 11, 753721. https:\/\/doi.org\/10.3389\/fcimb.2021.753721","DOI":"10.3389\/fcimb.2021.753721"},{"issue":"3","key":"1780_CR15","doi-asserted-by":"publisher","first-page":"64","DOI":"10.12779\/dnd.2017.16.3.64","volume":"16","author":"H Choi","year":"2017","unstructured":"Choi H, Choi N-Y, Lee K-Y, Lee YJ, Koh S-H (2017) Candesartan restores the amyloid beta-inhibited proliferation of neural stem cells by activating the phosphatidylinositol 3-kinase pathway. Dement Neurocogn Disord 16(3):64\u201371. https:\/\/doi.org\/10.12779\/dnd.2017.16.3.64","journal-title":"Dement Neurocogn Disord"},{"key":"1780_CR16","doi-asserted-by":"publisher","first-page":"586314","DOI":"10.3389\/fnins.2020.586314","volume":"14","author":"C Cosarderelioglu","year":"2020","unstructured":"Cosarderelioglu C, Nidadavolu LS, George CJ, Oh ES, Bennett DA, Walston JD, Abadir PM (2020) Brain renin\u2013angiotensin system at the intersect of physical and cognitive frailty. Front Neurosci 14:586314. https:\/\/doi.org\/10.3389\/fnins.2020.586314","journal-title":"Front Neurosci"},{"issue":"1","key":"1780_CR17","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1007\/s11357-022-00639-8","volume":"45","author":"C Cosarderelioglu","year":"2023","unstructured":"Cosarderelioglu C, Nidadavolu LS, George CJ, Marx-Rattner R, Powell L, Xue Q-L, Tian J, Oh ES, Ferrucci L, Dincer P (2023) Angiotensin receptor blocker use is associated with upregulation of the memory-protective angiotensin type 4 receptor (AT4R) in the postmortem brains of individuals without cognitive impairment. Geroscience 45(1):371\u2013384. https:\/\/doi.org\/10.1007\/s11357-022-00639-8","journal-title":"Geroscience"},{"key":"1780_CR18","doi-asserted-by":"publisher","first-page":"101355","DOI":"10.1016\/j.bbrep.2022.101355","volume":"32","author":"L De Dios","year":"2022","unstructured":"De Dios L, Collazo C, Inostroza-Nieves Y (2022) Renin-angiotensin-system increases phosphorylated tau and reactive oxygen species in human cortical neuron cell line. Biochem Biophys Rep 32:101355. https:\/\/doi.org\/10.1016\/j.bbrep.2022.101355","journal-title":"Biochem Biophys Rep"},{"issue":"18","key":"1780_CR19","doi-asserted-by":"publisher","first-page":"4640","DOI":"10.3390\/ijms20184640","volume":"20","author":"A De Mario","year":"2019","unstructured":"De Mario A, Peggion C, Massimino ML, Norante RP, Zulian A, Bertoli A, Sorgato MC (2019) The link of the prion protein with Ca2+ metabolism and ROS production, and the possible implication in A\u03b2 toxicity. Int J Mol Sci 20(18):4640. https:\/\/doi.org\/10.3390\/ijms20184640","journal-title":"Int J Mol Sci"},{"key":"1780_CR20","doi-asserted-by":"publisher","unstructured":"de Liyis BG, Sutedja JC, Kesuma PM I, Liyis S & Widyadharma IPE (2023) A review of literature on Compound 21-loaded gelatin nanoparticle: a promising nose-to-brain therapy for multi-infarct dementia. The Egyptian Journal of Neurology, Psychiatry and Neurosurgery, 59(1), 13. https:\/\/doi.org\/10.1186\/s41983-023-00621-x","DOI":"10.1186\/s41983-023-00621-x"},{"key":"1780_CR21","doi-asserted-by":"publisher","DOI":"10.2147\/JIR.S392599","author":"Y Deng","year":"2023","unstructured":"Deng Y, Wang S-Y, Wang Q-G, Xu Z-H, Peng Q, Chen S-Y, Zhu L, Zhang Y-D, Duan R (2023) Ave 0991 suppresses astrocyte-mediated neuroinflammation of Alzheimer\u2019s disease by enhancing autophagy. J Inflamm Res. https:\/\/doi.org\/10.2147\/JIR.S392599","journal-title":"J Inflamm Res"},{"issue":"9","key":"1780_CR22","doi-asserted-by":"publisher","first-page":"2911","DOI":"10.1096\/fj.11-182873","volume":"25","author":"Y Dong","year":"2011","unstructured":"Dong Y, Kataoka K, Tokutomi Y, Nako H, Nakamura T, Toyama K, Sueta D, Koibuchi N, Yamamoto E, Ogawa H (2011) Perindopril, a centrally active angiotensin-converting enzyme inhibitor, prevents cognitive impairment in mouse models of Alzheimer\u2019s disease. FASEB J 25(9):2911\u20132920. https:\/\/doi.org\/10.1096\/fj.11-182873","journal-title":"FASEB J"},{"key":"1780_CR23","doi-asserted-by":"publisher","unstructured":"Ebert U & Kirch W (1999) Effects of captopril and enalapril on electroencephalogram and cognitive performance in healthy volunteers.\u00a0Eur J Clin Pharmacol, 55(4), 255\u2013257. https:\/\/doi.org\/10.1007\/s002280050625","DOI":"10.1007\/s002280050625"},{"issue":"2","key":"1780_CR24","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1161\/HYPERTENSIONAHA.110.159889","volume":"57","author":"T Ebrahimian","year":"2011","unstructured":"Ebrahimian T, Li MW, Lemari\u00e9 CA, Simeone SM, Pagano PJ, Gaestel M, Schiffrin EL (2011) Mitogen-activated protein kinase\u2013activated protein kinase 2 in angiotensin II\u2013induced inflammation and hypertension: regulation of oxidative stress. Hypertension 57(2):245\u2013254. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.110.159889","journal-title":"Hypertension"},{"issue":"4","key":"1780_CR25","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1177\/2042098615589905","volume":"6","author":"R Esteras","year":"2015","unstructured":"Esteras R, Perez-Gomez MV, Rodriguez-Osorio L, Ortiz A, Fernandez-Fernandez B (2015) Combination use of medicines from two classes of renin\u2013angiotensin system blocking agents: risk of hyperkalemia, hypotension, and impaired renal function. Ther Adv Drug Saf 6(4):166\u2013176. https:\/\/doi.org\/10.1177\/2042098615589905","journal-title":"Ther Adv Drug Saf"},{"issue":"3","key":"1780_CR26","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1007\/s00401-019-02098-6","volume":"139","author":"CE Evans","year":"2020","unstructured":"Evans CE, Miners JS, Piva G, Willis CL, Heard DM, Kidd EJ, Good MA, Kehoe PG (2020) ACE2 activation protects against cognitive decline and reduces amyloid pathology in the Tg2576 mouse model of Alzheimer\u2019s disease. Acta Neuropathol 139(3):485\u2013502. https:\/\/doi.org\/10.1007\/s00401-019-02098-6","journal-title":"Acta Neuropathol"},{"issue":"8","key":"1780_CR27","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1016\/B978-0-323-99618-1.00025-8","volume":"13","author":"JA Evans","year":"2023","unstructured":"Evans JA, Mendonca P, Soliman KFA (2023) Involvement of Nrf2 activation and NF-kB pathway inhibition in the antioxidant and anti-inflammatory effects of hesperetin in activated BV-2 microglial cells. Brain Sci 13(8):1144. https:\/\/doi.org\/10.1016\/B978-0-323-99618-1.00025-8","journal-title":"Brain Sci"},{"issue":"1","key":"1780_CR28","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1038\/s41392-023-01588-0","volume":"8","author":"C Gao","year":"2023","unstructured":"Gao C, Jiang J, Tan Y, Chen S (2023) Microglia in neurodegenerative diseases: mechanism and potential therapeutic targets. Signal Transduct Target Ther 8(1):359. https:\/\/doi.org\/10.1038\/s41392-023-01588-0","journal-title":"Signal Transduct Target Ther"},{"issue":"2","key":"1780_CR29","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1111\/bcp.12511","volume":"79","author":"KL Goh","year":"2015","unstructured":"Goh KL, Bhaskaran K, Minassian C, Evans SJW, Smeeth L, Douglas IJ (2015) Angiotensin receptor blockers and risk of dementia: cohort study in UK clinical practice research datalink. Br J Clin Pharmacol 79(2):337\u2013350. https:\/\/doi.org\/10.1111\/bcp.12511","journal-title":"Br J Clin Pharmacol"},{"key":"1780_CR30","doi-asserted-by":"publisher","first-page":"101612","DOI":"10.1016\/j.arr.2022.101612","volume":"77","author":"F Gouveia","year":"2022","unstructured":"Gouveia F, Camins A, Ettcheto M, Bicker J, Falc\u00e3o A, Cruz MT, Fortuna A (2022) Targeting brain Renin-Angiotensin system for the prevention and treatment of Alzheimer\u2019s disease: past, present and future. Ageing Res Rev 77:101612. https:\/\/doi.org\/10.1016\/j.arr.2022.101612","journal-title":"Ageing Res Rev"},{"issue":"8","key":"1780_CR31","doi-asserted-by":"publisher","first-page":"e2012252\u2013e20122","DOI":"10.1001\/jamanetworkopen.2020.12252","volume":"3","author":"I Hajjar","year":"2020","unstructured":"Hajjar I, Okafor M, McDaniel D, Obideen M, Dee E, Shokouhi M, Quyyumi AA, Levey A, Goldstein F (2020) Effects of candesartan vs lisinopril on neurocognitive function in older adults with executive mild cognitive impairment: a randomized clinical trial. JAMA Netw Open 3(8):e2012252\u2013e2012252. https:\/\/doi.org\/10.1001\/jamanetworkopen.2020.12252","journal-title":"JAMA Netw Open"},{"issue":"3","key":"1780_CR32","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1161\/HYPERTENSIONAHA.121.1704","volume":"78","author":"JK Ho","year":"2021","unstructured":"Ho JK, Moriarty F, Manly JJ, Larson EB, Evans DA, Rajan KB, Hudak EM, Hassan L, Liu E, Sato N (2021) Blood-brain barrier crossing renin-angiotensin drugs and cognition in the elderly: a meta-analysis. Hypertension 78(3):629\u2013643. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.121.1704","journal-title":"Hypertension"},{"issue":"11","key":"1780_CR33","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1038\/s41581-019-0160-5","volume":"15","author":"A Ichihara","year":"2019","unstructured":"Ichihara A, Yatabe MS (2019) The (pro) renin receptor in health and disease. Nat Rev Nephrol 15(11):693\u2013712. https:\/\/doi.org\/10.1038\/s41581-019-0160-5","journal-title":"Nat Rev Nephrol"},{"issue":"4","key":"1780_CR34","doi-asserted-by":"publisher","first-page":"368504211054985","DOI":"10.1177\/00368504211054985","volume":"104","author":"T Ishijima","year":"2021","unstructured":"Ishijima T, Nakajima K (2021) Inflammatory cytokines TNF\u03b1, IL-1\u03b2, and IL-6 are induced in endotoxin- stimulated microglia through different signaling cascades. Sci Prog 104(4):368504211054985. https:\/\/doi.org\/10.1177\/00368504211054985","journal-title":"Sci Prog"},{"key":"1780_CR35","doi-asserted-by":"publisher","unstructured":"Iwai M & Horiuchi M (2009) Devil and angel in the renin\u2013angiotensin system: ACE\u2013angiotensin II\u2013AT1 receptor axis vs. ACE2\u2013angiotensin-(1\u20137)\u2013Mas receptor axis. Hypertension Research, 32(7), 533\u2013536. https:\/\/doi.org\/10.1038\/hr.2009.74","DOI":"10.1038\/hr.2009.74"},{"issue":"4","key":"1780_CR36","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.jash.2015.01.010","volume":"9","author":"J Iwanami","year":"2015","unstructured":"Iwanami J, Mogi M, Tsukuda K, Wang X-L, Nakaoka H, Kan-no H, Chisaka T, Bai H-Y, Shan B-S, Kukida M (2015) Direct angiotensin II type 2 receptor stimulation by compound 21 prevents vascular dementia. J Am Soc Hypertens 9(4):250\u2013256. https:\/\/doi.org\/10.1016\/j.jash.2015.01.010","journal-title":"J Am Soc Hypertens"},{"key":"1780_CR37","doi-asserted-by":"publisher","first-page":"101208","DOI":"10.1016\/j.arr.2020.101208","volume":"65","author":"A John","year":"2021","unstructured":"John A, Reddy PH (2021) Synaptic basis of Alzheimer\u2019s disease: focus on synaptic amyloid beta, P-tau and mitochondria. Ageing Res Rev 65:101208. https:\/\/doi.org\/10.1016\/j.arr.2020.101208","journal-title":"Ageing Res Rev"},{"key":"1780_CR38","doi-asserted-by":"publisher","unstructured":"Kaschina E, Steckelings UM, Unger T (2018) Hypertension and the renin-angiotensin-aldosterone system. In Encyclopedia of endocrine diseases (pp. 505\u2013510). Elsevier Editora. https:\/\/doi.org\/10.1016\/B978-0-12-801238-3.03969-6","DOI":"10.1016\/B978-0-12-801238-3.03969-6"},{"issue":"3","key":"1780_CR39","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1111\/fcp.12872","volume":"37","author":"B Kuber","year":"2023","unstructured":"Kuber B, Fadnavis M, Chatterjee B (2023) Role of angiotensin receptor blockers in the context of Alzheimer\u2019s disease. Fundam Clin Pharmacol 37(3):429\u2013445. https:\/\/doi.org\/10.1111\/fcp.12872","journal-title":"Fundam Clin Pharmacol"},{"issue":"2","key":"1780_CR40","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1042\/CS20200480","volume":"135","author":"J Kuriakose","year":"2021","unstructured":"Kuriakose J, Montezano AC, Touyz RM (2021) ACE2\/Ang-(1\u20137)\/Mas1 axis and the vascular system: vasoprotection to COVID-19-associated vascular disease. Clin Sci 135(2):387\u2013407. https:\/\/doi.org\/10.1042\/CS20200480","journal-title":"Clin Sci"},{"key":"1780_CR41","doi-asserted-by":"publisher","first-page":"129","DOI":"10.3389\/fnagi.2017.00129","volume":"9","author":"JL Labandeira-Garcia","year":"2017","unstructured":"Labandeira-Garcia JL, Rodr\u00edguez-Perez AI, Garrido-Gil P, Rodriguez-Pallares J, Lanciego JL, Guerra MJ (2017) Brain renin-angiotensin system and microglial polarization: implications for aging and neurodegeneration. Front Aging Neurosci 9:129. https:\/\/doi.org\/10.3389\/fnagi.2017.00129","journal-title":"Front Aging Neurosci"},{"issue":"2","key":"1780_CR42","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1080\/14737175.2020.1708195","volume":"20","author":"T Lebouvier","year":"2020","unstructured":"Lebouvier T, Chen Y, Duriez P, Pasquier F, Bordet R (2020) Antihypertensive agents in Alzheimer\u2019s disease: beyond vascular protection. Expert Rev Neurother 20(2):175\u2013187. https:\/\/doi.org\/10.1080\/14737175.2020.1708195","journal-title":"Expert Rev Neurother"},{"issue":"14","key":"1780_CR43","doi-asserted-by":"publisher","first-page":"7688","DOI":"10.3390\/ijms22147688","volume":"22","author":"P Li","year":"2021","unstructured":"Li P, Chang M (2021) Roles of PRR-mediated signaling pathways in the regulation of oxidative stress and inflammatory diseases. Int J Mol Sci 22(14):7688. https:\/\/doi.org\/10.3390\/ijms22147688","journal-title":"Int J Mol Sci"},{"key":"1780_CR44","doi-asserted-by":"publisher","unstructured":"Li T, Huang HY, Wang HD, Gao CC, Liang H, Deng CL & Zhou ML (2022) Restoration of brain angiotensin-converting enzyme 2 alleviates neurological deficits after severe traumatic brain injury via mitigation of pyroptosis and apoptosis.\u00a0J Neurotrauma, 39(5-6):423\u2013434. https:\/\/doi.org\/10.1089\/neu.2021.0382","DOI":"10.1089\/neu.2021.0382"},{"issue":"4","key":"1780_CR45","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.3233\/JAD-200770","volume":"78","author":"X Li","year":"2020","unstructured":"Li X, Xuan W, Chen D, Gao H, Wang G, Guo Q, Wang Y, Song H, Cai B (2020) Research progress of Alzheimer\u2019s disease therapeutic drugs: based on renin-angiotensin system axis. J Alzheimers Dis 78(4):1315\u20131338. https:\/\/doi.org\/10.3233\/JAD-200770","journal-title":"J Alzheimers Dis"},{"key":"1780_CR46","doi-asserted-by":"crossref","unstructured":"Lithell H, Hansson L, Skoog I, Elmfeldt D, Hofman A, Olofsson B, ... SCOPE Study Group (2003) The Study on Cognition and Prognosis in the Elderly (SCOPE): principal results of a randomized double-blind intervention trial. J Hypertension 21(5):875-886","DOI":"10.1097\/00004872-200305000-00011"},{"key":"1780_CR47","doi-asserted-by":"publisher","DOI":"10.2147\/JIR.S490418","author":"N Li","year":"2024","unstructured":"Li N, Hao L, Li S, Deng J, Yu F, Zhang J, Nie A, Hu X (2024) The NRF-2\/HO-1 signaling pathway: a promising therapeutic target for metabolic dysfunction-associated steatotic liver disease. J Inflamm Res. https:\/\/doi.org\/10.2147\/JIR.S490418","journal-title":"J Inflamm Res"},{"issue":"4","key":"1780_CR48","doi-asserted-by":"publisher","first-page":"1748","DOI":"10.14336\/AD.2023.1201","volume":"15","author":"R Liu","year":"2024","unstructured":"Liu R, Collier JM, Abdul-Rahman N-H, Capuk O, Zhang Z, Begum G (2024) Dysregulation of ion channels and transporters and blood-brain barrier dysfunction in Alzheimer\u2019s disease and vascular dementia. Aging Dis 15(4):1748. https:\/\/doi.org\/10.14336\/AD.2023.1201","journal-title":"Aging Dis"},{"key":"1780_CR49","doi-asserted-by":"publisher","unstructured":"Loera-Valencia R, Eroli F, Garcia-Ptacek S & Maioli S (2021) Brain renin\u2013angiotensin system as novel and potential therapeutic target for Alzheimer\u2019s disease. Int J Mol Sci 22(18):10139. https:\/\/doi.org\/10.3390\/ijms221810139","DOI":"10.3390\/ijms221810139"},{"key":"1780_CR50","doi-asserted-by":"publisher","first-page":"1565270","DOI":"10.3389\/fphys.2025.1565270","volume":"16","author":"LC Lucas","year":"2025","unstructured":"Lucas LC, Kimbark KD, Vernail VL, Silberman Y, Arnold AC (2025) Angiotensin-(1\u20137) protective effects in neurocognitive disorders: molecular mechanisms to therapeutic implications. Front Physiol 16:1565270. https:\/\/doi.org\/10.3389\/fphys.2025.1565270","journal-title":"Front Physiol"},{"key":"1780_CR51","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2024.105378","author":"SK Lundin","year":"2024","unstructured":"Lundin SK, Hu X, Feng J, Lundin KK, Li L, Chen Y, Schulz PE, Tao C (2024) Association between risk of Alzheimer\u2019s disease and related dementias and angiotensin receptor \u2161 blockers treatment for individuals with hypertension in high-volume claims data. EBioMedicine. https:\/\/doi.org\/10.1016\/j.ebiom.2024.105378","journal-title":"EBioMedicine"},{"issue":"3","key":"1780_CR52","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1016\/j.bbrc.2019.06.063","volume":"516","author":"Y Luo","year":"2019","unstructured":"Luo Y, Zhang Q, Ding J, Yu M, Jiang J, Yang F, Wang S, Wang A, Wang L, Wu S (2019) Roles of I2PP2A in the downregulation of eNOS Ser1177 phosphorylation by angiotensin II-activated PP2A. Biochem Biophys Res Commun 516(3):613\u2013618. https:\/\/doi.org\/10.1016\/j.bbrc.2019.06.063","journal-title":"Biochem Biophys Res Commun"},{"key":"1780_CR53","doi-asserted-by":"publisher","unstructured":"Lucero J, Davis G, McDonald JD & Lund AK (2019) Mixed vehicle emissions induces angiotensin II and cerebral microvascular angiotensin receptor expression in C57Bl\/6 mice and promotes alterations in integrity in a blood-brain barrier Coculture model. Toxicological Sciences, 170(2), 525\u2013535.10. https:\/\/doi.org\/10.1093\/toxsci\/kfz121","DOI":"10.1093\/toxsci\/kfz121"},{"key":"1780_CR54","doi-asserted-by":"publisher","first-page":"1452959","DOI":"10.3389\/fphys.2024.1452959","volume":"15","author":"M Makuch-Martins","year":"2024","unstructured":"Makuch-Martins M, Vieira-Morais CG, Perego SM, Ruggeri A, Ceroni A, Michelini LC (2024) Angiotensin II, blood\u2013brain barrier permeability, and microglia interplay during the transition from pre-to hypertensive phase in spontaneously hypertensive rats. Front Physiol 15:1452959. https:\/\/doi.org\/10.3389\/fphys.2024.1452959","journal-title":"Front Physiol"},{"issue":"9","key":"1780_CR55","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1016\/j.cellsig.2011.05.013","volume":"23","author":"K Min","year":"2011","unstructured":"Min K, Lee JT, Joe E, Kwon TK (2011) An I\u03baB\u03b1 phosphorylation inhibitor induces heme oxygenase-1 (HO-1) expression through the activation of reactive oxygen species (ROS)\u2013Nrf2\u2013ARE signaling and ROS\u2013PI3K\/Akt signaling in an NF-\u03baB-independent mechanism. Cell Signal 23(9):1505\u20131513. https:\/\/doi.org\/10.1016\/j.cellsig.2011.05.013","journal-title":"Cell Signal"},{"key":"1780_CR56","doi-asserted-by":"publisher","unstructured":"Mishra S, Pattanaik S, Sahoo S, Prusty SK, Sahu PK & Das D (2025) New insights into repurposing of renin-angiotensin system inhibitors against Alzheimer\u2019s disease.\u00a0J Appl Pharm Sci 15(3), 039\u2013049. https:\/\/doi.org\/10.7324\/JAPS.2024.194605","DOI":"10.7324\/JAPS.2024.194605"},{"issue":"1","key":"1780_CR57","doi-asserted-by":"publisher","first-page":"169649","DOI":"10.1155\/2012\/169649","volume":"2012","author":"M Mogi","year":"2012","unstructured":"Mogi M, Iwanami J, Horiuchi M (2012) Roles of brain angiotensin II in cognitive function and dementia. Int J Hypertens 2012(1):169649. https:\/\/doi.org\/10.1155\/2012\/169649","journal-title":"Int J Hypertens"},{"key":"1780_CR58","doi-asserted-by":"publisher","DOI":"10.1007\/s12035-025-04725-8","author":"R Mukherjee","year":"2025","unstructured":"Mukherjee R, Rana R, Mehan S, Khan Z, Das Gupta G, Narula AS, Samant R (2025) Investigating the interplay between the Nrf2\/Keap1\/HO-1\/SIRT-1 pathway and the p75NTR\/PI3K\/Akt\/MAPK cascade in neurological disorders: mechanistic insights and therapeutic innovations. Mol Neurobiol. https:\/\/doi.org\/10.1007\/s12035-025-04725-8","journal-title":"Mol Neurobiol"},{"key":"1780_CR59","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11906-019-1011-2","volume":"22","author":"P Nakagawa","year":"2020","unstructured":"Nakagawa P, Gomez J, Grobe JL, Sigmund CD (2020) The renin-angiotensin system in the central nervous system and its role in blood pressure regulation. Curr Hypertens Rep 22:1\u201310. https:\/\/doi.org\/10.1007\/s11906-019-1011-2","journal-title":"Curr Hypertens Rep"},{"key":"1780_CR60","doi-asserted-by":"publisher","unstructured":"Nejat R & Sadr AS (2020) Are losartan and imatinib effective against SARS-CoV2 pathogenesis? A pathophysiologic-based in silico study. In Silico Pharmacology, 9(1), 1. https:\/\/doi.org\/10.1007\/s40203-020-00058-7","DOI":"10.1007\/s40203-020-00058-7"},{"key":"1780_CR61","doi-asserted-by":"publisher","unstructured":"Noureddine FY, Altara R, Fan F, Yabluchanskiy A, Booz GW & Zouein FA (2020) Impact of the renin\u2013angiotensin system on the endothelium in vascular dementia: Unresolved issues and future perspectives. Int J Mol Sci, 21(12):4268. https:\/\/doi.org\/10.3390\/ijms21124268","DOI":"10.3390\/ijms21124268"},{"key":"1780_CR62","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.nbd.2014.04.018","volume":"68","author":"B Ongali","year":"2014","unstructured":"Ongali B, Nicolakakis N, Tong XK, Aboulkassim T, Papadopoulos P, Rosa-Neto P, Lecrux C, Imboden H, Hamel E (2014) Angiotensin II type 1 receptor blocker losartan prevents and rescues cerebrovascular, neuropathological and cognitive deficits in an Alzheimer\u2019s disease model. Neurobiol Dis 68:126\u2013136. https:\/\/doi.org\/10.1016\/j.nbd.2014.04.018","journal-title":"Neurobiol Dis"},{"key":"1780_CR63","doi-asserted-by":"publisher","unstructured":"Olufunmilayo EO, Gerke-Duncan MB & Holsinger RD (2023) Oxidative stress and antioxidants in neurodegenerative disorders. Antioxidants, 12(2):517. https:\/\/doi.org\/10.3390\/antiox12020517","DOI":"10.3390\/antiox12020517"},{"key":"1780_CR64","doi-asserted-by":"crossref","unstructured":"Pflanzner T, R Kuhlmann C & U Pietrzik C (2010) Blood-brain-barrier models for the investigation of transporter-and receptor-mediated amyloid-\u03b2 clearance in Alzheimer's disease.\u00a0Curr Alzheimer Res, 7(7), 578\u2013590","DOI":"10.2174\/156720510793499066"},{"key":"1780_CR65","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.biopha.2017.07.091","volume":"94","author":"S Patel","year":"2017","unstructured":"Patel S, Rauf A, Khan H, Abu-Izneid T (2017) Renin-angiotensin-aldosterone (RAAS): The ubiquitous system for homeostasis and pathologies. Biomed Pharmacother 94:317\u2013325. https:\/\/doi.org\/10.1016\/j.biopha.2017.07.091","journal-title":"Biomed Pharmacother"},{"issue":"3","key":"1780_CR66","doi-asserted-by":"publisher","first-page":"e58339","DOI":"10.1371\/journal.pone.0058339","volume":"8","author":"H Peng","year":"2013","unstructured":"Peng H, Li W, Seth DM, Nair AR, Francis J, Feng Y (2013) (Pro) renin receptor mediates both angiotensin II-dependent and-independent oxidative stress in neuronal cells. PLoS One 8(3):e58339. https:\/\/doi.org\/10.1371\/journal.pone.0058339","journal-title":"PLoS One"},{"issue":"9287","key":"1780_CR67","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1016\/S0140-6736(01)06178-5","volume":"358","author":"PROGRESS Collaborative Group","year":"2001","unstructured":"PROGRESS Collaborative Group (2001) Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6105 individuals with previous stroke or transient ischaemic attack. The Lancet 358(9287):1033\u20131041. https:\/\/doi.org\/10.1016\/S0140-6736(01)06178-5","journal-title":"The Lancet"},{"key":"1780_CR68","doi-asserted-by":"publisher","unstructured":"PROGRESS Collaborative Group (2003) Effects of blood pressure lowering with perindopril and indapamide therapy on dementia and cognitive decline in patients with cerebrovascular disease. Arch Intern Med, 163(9), 1069\u20131075. https:\/\/doi.org\/10.1001\/archinte.163.9.1069","DOI":"10.1001\/archinte.163.9.1069"},{"key":"1780_CR69","doi-asserted-by":"publisher","first-page":"205873842097490","DOI":"10.1177\/2058738420974900","volume":"34","author":"S Qie","year":"2020","unstructured":"Qie S, Ran Y, Lu X, Su W, Li W, Xi J, Gong W, Liu Z (2020) Candesartan modulates microglia activation and polarization via NF-\u03baB signaling pathway. Int J Immunopathol Pharmacol 34:2058738420974900. https:\/\/doi.org\/10.1177\/2058738420974900","journal-title":"Int J Immunopathol Pharmacol"},{"key":"1780_CR70","doi-asserted-by":"publisher","DOI":"10.1007\/s43440-025-00737-2","author":"W Quan","year":"2025","unstructured":"Quan W, Zhang S-X, Zhang X-Y, Chen X, Yang C, Li Z-Y, Hu R (2025) The application of telmisartan in central nervous system disorders. Pharmacol Rep. https:\/\/doi.org\/10.1007\/s43440-025-00737-2","journal-title":"Pharmacol Rep"},{"key":"1780_CR71","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2015.00136","volume":"7","author":"A Ramanathan","year":"2015","unstructured":"Ramanathan A, Nelson AR, Sagare AP, Zlokovic BV (2015) Impaired vascular-mediated clearance of brain amyloid beta in Alzheimer\u2019s disease: the role, regulation and restoration of LRP1. Front Aging Neurosci 7:136. https:\/\/doi.org\/10.3389\/fnagi.2015.00136","journal-title":"Front Aging Neurosci"},{"issue":"21","key":"1780_CR72","doi-asserted-by":"publisher","first-page":"12841","DOI":"10.3390\/ijms232112841","volume":"23","author":"P Rawat","year":"2022","unstructured":"Rawat P, Sehar U, Bisht J, Selman A, Culberson J, Reddy PH (2022) Phosphorylated tau in Alzheimer\u2019s disease and other tauopathies. Int J Mol Sci 23(21):12841. https:\/\/doi.org\/10.3390\/ijms232112841","journal-title":"Int J Mol Sci"},{"issue":"6","key":"1780_CR73","doi-asserted-by":"publisher","first-page":"484","DOI":"10.2174\/0929866527666191230103739","volume":"27","author":"VT Ribeiro","year":"2020","unstructured":"Ribeiro VT, de Souza LC, Simoes e Silva AC (2020) Renin-angiotensin system and Alzheimer\u2019s disease pathophysiology: from the potential interactions to therapeutic perspectives. Protein Pept Lett 27(6):484\u2013511. https:\/\/doi.org\/10.2174\/0929866527666191230103739","journal-title":"Protein Pept Lett"},{"issue":"1","key":"1780_CR74","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1186\/s13287-025-04430-2","volume":"16","author":"J Rodr\u00edguez-Pallares","year":"2025","unstructured":"Rodr\u00edguez-Pallares J, Garcia-Crivaro LA, Parga JA, Labandeira-Garcia JL (2025) Renin-angiotensin system as an emerging target to modulate adult neurogenesis in health and disease. Stem Cell Res Ther 16(1):332. https:\/\/doi.org\/10.1186\/s13287-025-04430-2","journal-title":"Stem Cell Res Ther"},{"issue":"5","key":"1780_CR75","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1007\/s11357-020-00231-y","volume":"42","author":"J Royea","year":"2020","unstructured":"Royea J, Hamel E (2020) Brain angiotensin II and angiotensin IV receptors as potential Alzheimer\u2019s disease therapeutic targets. Geroscience 42(5):1237\u20131256. https:\/\/doi.org\/10.1007\/s11357-020-00231-y","journal-title":"Geroscience"},{"key":"1780_CR76","doi-asserted-by":"publisher","DOI":"10.37349\/emed.2021.00046","author":"NL RukavinaMikusic","year":"2021","unstructured":"RukavinaMikusic NL, Pineda AM, Gironacci MM (2021) Angiotensin-(1\u20137) and MasReceptor in the brain. Explor Med. https:\/\/doi.org\/10.37349\/emed.2021.00046","journal-title":"Explor Med"},{"key":"1780_CR77","doi-asserted-by":"publisher","unstructured":"Sampson AK, Irvine JC, Shihata WA, Dragoljevic D, Lumsden N, Huet O & Chin\u2010Dusting JP (2016) Compound 21, a selective agonist of angiotensin AT2 receptors, prevents endothelial inflammation and leukocyte adhesion in vitro and in vivo. British journal of pharmacology, 173(4), 729\u2013740. https:\/\/doi.org\/10.1111\/bph.13063","DOI":"10.1111\/bph.13063"},{"issue":"10","key":"1780_CR78","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1042\/CS20120078","volume":"123","author":"JM Saavedra","year":"2012","unstructured":"Saavedra JM (2012) Angiotensin II AT1 receptor blockers as treatments for inflammatory brain disorders. Clin Sci 123(10):567\u2013590. https:\/\/doi.org\/10.1042\/CS20120078","journal-title":"Clin Sci"},{"key":"1780_CR79","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11906-018-0900-0","volume":"20","author":"R Satou","year":"2018","unstructured":"Satou R, Penrose H, Navar LG (2018) Inflammation as a regulator of the renin-angiotensin system and blood pressure. Curr Hypertens Rep 20:1\u20139. https:\/\/doi.org\/10.1007\/s11906-018-0900-0","journal-title":"Curr Hypertens Rep"},{"key":"1780_CR80","doi-asserted-by":"publisher","unstructured":"Shareena G, Kumar D (2023) Exploring the role of tau proteins in Alzheimer\u2019s disease from typical functioning MAPs to aberrant fibrillary deposits in the brain. In Deciphering Drug Targets for Alzheimer\u2019s Disease (pp. 321\u2013349). Springer. https:\/\/doi.org\/10.1007\/978-981-99-2657-2_14","DOI":"10.1007\/978-981-99-2657-2_14"},{"issue":"4","key":"1780_CR81","doi-asserted-by":"publisher","first-page":"66","DOI":"10.3390\/mps3040066","volume":"3","author":"Y Sidorova","year":"2020","unstructured":"Sidorova Y, Domanskyi A (2020) Detecting oxidative stress biomarkers in neurodegenerative disease models and patients. Methods Protoc 3(4):66. https:\/\/doi.org\/10.3390\/mps3040066","journal-title":"Methods Protoc"},{"key":"1780_CR82","unstructured":"Skillb\u00e4ck T (2019) Biochemical markers in dementia-Exploring Swedish registry data and the human proteome. https:\/\/hdl.handle.net\/2077\/60288"},{"issue":"4","key":"1780_CR83","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1016\/j.bbrc.2013.08.091","volume":"439","author":"YI Sohn","year":"2013","unstructured":"Sohn YI, Lee NJ, Chung A, Saavedra JM, Turner RS, Pak DTS, Hoe H-S (2013) Antihypertensive drug valsartan promotes dendritic spine density by altering AMPA receptor trafficking. Biochem Biophys Res Commun 439(4):464\u2013470. https:\/\/doi.org\/10.1016\/j.bbrc.2013.08.091","journal-title":"Biochem Biophys Res Commun"},{"key":"1780_CR84","doi-asserted-by":"publisher","unstructured":"Subhani MK, Sabani A, Omer O, Kheirelsid F, Srour AK, Omer Sr, O, Kheirelsid FE (2025) Impact of renin-angiotensin-aldosterone system modulation on cognitive and neuropsychiatric outcomes: a systematic review of clinical and mechanistic evidence. Cureus 17(7). https:\/\/doi.org\/10.7759\/cureus.87557","DOI":"10.7759\/cureus.87557"},{"issue":"3","key":"1780_CR85","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1161\/HYPERTENSIONAHA.114.0469","volume":"65","author":"S Sriramula","year":"2014","unstructured":"Sriramula S, Xia H, Xu P, Lazartigues E (2014) Brain-targeted ACE2 overexpression attenuates neurogenic hypertension by inhibiting COX mediated inflammation. Hypertension 65(3):577. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.114.0469","journal-title":"Hypertension"},{"issue":"11","key":"1780_CR86","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1038\/hr.2011.105","volume":"34","author":"H Takahashi","year":"2011","unstructured":"Takahashi H, Yoshika M, Komiyama Y, Nishimura M (2011) The central mechanism underlying hypertension: a review of the roles of sodium ions, epithelial sodium channels, the renin\u2013angiotensin\u2013aldosterone system, oxidative stress and endogenous digitalis in the brain. Hypertens Res 34(11):1147\u20131160. https:\/\/doi.org\/10.1038\/hr.2011.105","journal-title":"Hypertens Res"},{"issue":"4","key":"1780_CR87","doi-asserted-by":"publisher","first-page":"e13251","DOI":"10.1111\/bpa.13251","volume":"34","author":"HM Tayler","year":"2024","unstructured":"Tayler HM, Skrobot OA, Baron DH, Kehoe PG, Miners JS (2024) Dysregulation of the renin-angiotensin system in vascular dementia. Brain Pathol 34(4):e13251. https:\/\/doi.org\/10.1111\/bpa.13251","journal-title":"Brain Pathol"},{"key":"1780_CR88","doi-asserted-by":"publisher","first-page":"175623","DOI":"10.1016\/j.ejphar.2023.175623","volume":"946","author":"V Tiwari","year":"2023","unstructured":"Tiwari V, Singh J, Tiwari P, Chaturvedi S, Gupta S, Mishra A, Singh S, Wahajuddin M, Hanif K, Shukla S (2023) ACE2\/ANG-(1\u20137)\/MasReceptor axis activation prevents inflammation and improves cognitive functions in streptozotocin induced rat model of Alzheimer\u2019s disease-like phenotypes. Eur J Pharmacol 946:175623. https:\/\/doi.org\/10.1016\/j.ejphar.2023.175623","journal-title":"Eur J Pharmacol"},{"issue":"6","key":"1780_CR89","doi-asserted-by":"publisher","first-page":"afaf140","DOI":"10.1093\/ageing\/afaf140","volume":"54","author":"A Ungar","year":"2025","unstructured":"Ungar A, Latini E, Rivasi G, Mossello E, Oxford University Press (2025) Renin-angiotensin system inhibition and risk of dementia in hypertensive patients. An old dilemma. Age Ageing 54(6):afaf140. https:\/\/doi.org\/10.1093\/ageing\/afaf140","journal-title":"Age Ageing"},{"key":"1780_CR90","doi-asserted-by":"publisher","unstructured":"Vandendriessche C, Kapogiannis D & Vandenbroucke RE (2022) Biomarker and therapeutic potential of peripheral extracellular vesicles in Alzheimer\u2019s disease. Advanced drug delivery reviews, 190, 114486. https:\/\/doi.org\/10.1016\/j.addr.2022.114486","DOI":"10.1016\/j.addr.2022.114486"},{"issue":"10","key":"1780_CR91","doi-asserted-by":"publisher","first-page":"136","DOI":"10.3978\/j.issn.2305-5839.2015.03.49","volume":"3","author":"W-Y Wang","year":"2015","unstructured":"Wang W-Y, Tan M-S, Yu J-T, Tan L (2015) Role of pro-inflammatory cytokines released from microglia in Alzheimer\u2019s disease. Ann Transl Med 3(10):136. https:\/\/doi.org\/10.3978\/j.issn.2305-5839.2015.03.49","journal-title":"Ann Transl Med"},{"issue":"1","key":"1780_CR92","doi-asserted-by":"publisher","first-page":"147","DOI":"10.3233\/JAD-2012-120763","volume":"32","author":"W Wharton","year":"2012","unstructured":"Wharton W, Stein JH, Korcarz C, Sachs J, Olson SR, Zetterberg H, Carlsson CM (2012) The effects of ramipril in individuals at risk for Alzheimer\u2019s disease: results of a pilot clinical trial. J Alzheimers Dis 32(1):147\u2013156. https:\/\/doi.org\/10.3233\/JAD-2012-120763","journal-title":"J Alzheimers Dis"},{"issue":"4","key":"1780_CR93","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1007\/s12012-022-09730-0","volume":"22","author":"H Wu","year":"2022","unstructured":"Wu H, Sun Q, Yuan S, Wang J, Li F, Gao H, Chen X, Yang R, Xu J (2022) AT1 receptors: their actions from hypertension to cognitive impairment. Cardiovasc Toxicol 22(4):311\u2013325. https:\/\/doi.org\/10.1007\/s12012-022-09730-0","journal-title":"Cardiovasc Toxicol"},{"issue":"1","key":"1780_CR94","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.yexcr.2015.06.010","volume":"336","author":"X Xiao","year":"2015","unstructured":"Xiao X, Zhang C, Ma X, Miao H, Wang J, Liu L, Chen S, Zeng R, Chen Y, Bihl JC (2015) Angiotensin-(1\u20137) counteracts angiotensin II-induced dysfunction in cerebral endothelial cells via modulating Nox2\/ROS and PI3K\/NO pathways. Exp Cell Res 336(1):58\u201365. https:\/\/doi.org\/10.1016\/j.yexcr.2015.06.010","journal-title":"Exp Cell Res"},{"issue":"3","key":"1780_CR95","doi-asserted-by":"publisher","first-page":"343","DOI":"10.2174\/1567202618666211012095210","volume":"18","author":"X Xue","year":"2021","unstructured":"Xue X, Duan R, Zhang Q-Q, Wang S-Y, Gong P-Y, E Y, Zhang Y-D, Jiang T (2021) A non-peptidic MAS1 agonist AVE0991 alleviates hippocampal synaptic degeneration in rats with chronic cerebral hypoperfusion. Curr Neurovasc Res 18(3):343\u2013350. https:\/\/doi.org\/10.2174\/1567202618666211012095210","journal-title":"Curr Neurovasc Res"},{"issue":"9","key":"1780_CR96","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1038\/hr.2013.51","volume":"36","author":"S Yagi","year":"2013","unstructured":"Yagi S, Akaike M, Ise T, Ueda Y, Iwase T, Sata M (2013) Renin\u2013angiotensin\u2013aldosterone system has a pivotal role in cognitive impairment. Hypertens Res 36(9):753\u2013758. https:\/\/doi.org\/10.1038\/hr.2013.51","journal-title":"Hypertens Res"},{"key":"1780_CR97","doi-asserted-by":"crossref","unstructured":"Yamada K, Iyer SN, Chappell MC, Ganten D & Ferrario CM (1998) Converting enzyme determines plasma clearance of angiotensin-(1\u20137). Hypertension, 32(3), 496\u2013502","DOI":"10.1161\/01.HYP.32.3.496"},{"key":"1780_CR98","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.brainres.2010.07.006","volume":"1352","author":"K Yamada","year":"2010","unstructured":"Yamada K, Uchida S, Takahashi S, Takayama M, Nagata Y, Suzuki N, Shirakura S, Kanda T (2010) Effect of a centrally active angiotensin-converting enzyme inhibitor, perindopril, on cognitive performance in a mouse model of Alzheimer\u2019s disease. Brain Res 1352:176\u2013186. https:\/\/doi.org\/10.1016\/j.brainres.2010.07.006","journal-title":"Brain Res"},{"key":"1780_CR99","doi-asserted-by":"publisher","first-page":"149400","DOI":"10.1016\/j.brainres.2024.149400","volume":"1850","author":"S Yasmin","year":"2025","unstructured":"Yasmin S, Ashique S, Taj T, Garg A, Das J, Shorog E, Bhui U, Pal R, Selim S, Panigrahy UP (2025) The role of ACE inhibitors and ARBs in preserving cognitive function via hypertension management: a critical update. Brain Res 1850:149400. https:\/\/doi.org\/10.1016\/j.brainres.2024.149400","journal-title":"Brain Res"},{"issue":"5","key":"1780_CR100","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1161\/HYPERTENSIONAHA.115.03624","volume":"66","author":"CN Young","year":"2015","unstructured":"Young CN, Davisson RL (2015) Angiotensin-II, the brain, and hypertension: an update. Hypertension 66(5):920\u2013926. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.115.03624","journal-title":"Hypertension"},{"issue":"10","key":"1780_CR101","doi-asserted-by":"publisher","first-page":"C803","DOI":"10.1152\/ajpcell.00223.2014","volume":"308","author":"CN Young","year":"2015","unstructured":"Young CN, Li A, Dong FN, Horwath JA, Clark CG, Davisson RL (2015) Endoplasmic reticulum and oxidant stress mediate nuclear factor-\u03baB activation in the subfornical organ during angiotensin II hypertension. Am J Physiol Cell Physiol 308(10):C803\u2013C812. https:\/\/doi.org\/10.1152\/ajpcell.00223.2014","journal-title":"Am J Physiol Cell Physiol"},{"issue":"1","key":"1780_CR102","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11906-023-01266-0","volume":"26","author":"Z Zhou","year":"2024","unstructured":"Zhou Z, Orchard SG, Nelson MR, Fravel MA, Ernst ME (2024) Angiotensin receptor blockers and cognition: a scoping review. Curr Hypertens Rep 26(1):1\u201319. https:\/\/doi.org\/10.1007\/s11906-023-01266-0","journal-title":"Curr Hypertens Rep"},{"issue":"1","key":"1780_CR103","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.nucmedbio.2005.08.005","volume":"33","author":"TG Zober","year":"2006","unstructured":"Zober TG, Mathews WB, Seckin E, Yoo SE, Hilton J, Xia J, Sandberg K, Ravert HT, Dannals RF, Szabo Z (2006) PET imaging of the AT1 receptor with [11C]KR31173. Nucl Med Biol 33(1):5\u201313. https:\/\/doi.org\/10.1016\/j.nucmedbio.2005.08.005","journal-title":"Nucl Med Biol"}],"container-title":["Metabolic Brain Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11011-025-01780-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11011-025-01780-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11011-025-01780-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T10:53:10Z","timestamp":1771411990000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11011-025-01780-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,18]]},"references-count":103,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1780"],"URL":"https:\/\/doi.org\/10.1007\/s11011-025-01780-x","relation":{},"ISSN":["1573-7365"],"issn-type":[{"value":"1573-7365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,18]]},"assertion":[{"value":"19 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The authors assert that they do not have any known financial interests or personal relationships that could be perceived as influencing the work reported in this paper.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interest"}}],"article-number":"36"}}